Abstract
Pharmacist led medication therapy management (MTM) intervention is a process that is designed to optimize outcomes and has been shown to offer significant improvements in the management of chronic disease and promote clinical and economic benefits. A non-randomized study utilizing prospective data was conducted between March 2021 and May 2023 across three clinical sites.
Participants were enrolled in MTM services with either diabetes, hypertension, and/or dyslipidemia diagnosis. Participants completed surveys at baseline, six months, and one year related to demographics, medication adherence, patient satisfaction and quality of life. Clinical data was collected at baseline and one year with the primary outcome the change in Glycated Hemoglobin (HbA1c) and blood pressure. Sixty-nine participants were recruited, 52.2% male, 44.9% rural with mean age of sixty.
Mean HbA1c at final follow-up was improved by 0.7% (P =.001) with 16 participants improving below an HbA1c of 8% (P < .001). Eleven participants at final follow-up significantly improved blood pressure below the 140/90 threshold (P = .012). Estimated medical cost-care avoidance benefits to patients were $51,948 for HbA1c reductions and $35,277 for participants that lowered their blood pressure. Pharmacist-led MTM interventions can have a significant impact on clinical and economic outcomes related to diabetes and blood pressure.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Recommended Citation
Robbins, Christopher; Miller, Erin; Middendorf, Alex; Van Gilder, Deidra; and Pinto, Sharrel (2026) "Impact of a Pharmacist-Based Community Intervention to Improve Outcomes for Patients with Diabetes and Hypertension," Health Behavior Research: Vol. 9: No. 1.
